Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker? ; volume:23 ; number:1 ; day:22 ; month:5 ; year:2019 ; pages:1-2 ; date:12.2019
Critical care ; 23, Heft 1 (22.5.2019), 1-2, 12.2019
- Creator
-
Honore, Patrick M.
Bels, David De
Attou, Rachid
Redant, Sebastien
Gallerani, Andrea
Kashani, Kianoush
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-019-2469-7
- URN
-
urn:nbn:de:101:1-2020022023301430592480
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honore, Patrick M.
- Bels, David De
- Attou, Rachid
- Redant, Sebastien
- Gallerani, Andrea
- Kashani, Kianoush
- SpringerLink (Online service)
Other Objects (12)
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
The challenge of removal of sepsis markers by continuous hemofiltration
Is prolonged intermittent renal replacement therapy actually safe for hemodynamically unstable patients
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
VCO2 calorimetry: stop tossing stones, it’s time for building!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
The challenge of removal of sepsis markers by continuous hemofiltration
Is prolonged intermittent renal replacement therapy actually safe for hemodynamically unstable patients
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Normal saline as resuscitation fluid in critically ill patients: not dead yet!
VCO2 calorimetry: stop tossing stones, it’s time for building!
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not
Oxidative stress markers and septic acute kidney injury: Novel research avenue or road to nowhere?
Passive leg raising test with minimally invasive monitoring: the way forward for guiding septic shock resuscitation?
Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
The challenge of removal of sepsis markers by continuous hemofiltration
Is prolonged intermittent renal replacement therapy actually safe for hemodynamically unstable patients
Is an EAA > 0.6 in severe COVID-19 patients synonymous with a toxic and pro-inflammatory endotoxin profile, and should we treat it?
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients
Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
Beneficial effects of antioxidant therapy in crush syndrome in a rodent model: enough evidences to be used in humans?
Normal saline as resuscitation fluid in critically ill patients: not dead yet!